Predict your next investment

ROSLINCT company logo
HEALTHCARE | Drug Manufacturing
roslinct.com

See what CB Insights has to offer

Business Relationships

4

ROSLINCT Partners & Customers

4 Partners and customers

ROSLINCT has 4 strategic partners and customers. ROSLINCT recently partnered with ReproCELL on October 10, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

10/10/2018

Client

ReproCELL

Japan

Press Release: ROSLINCT and REPROCELL awarded £1.2 million from Innovate UK for clinical-grade stem cell production

Edinburgh , UK and Glasgow , UK : ROSLINCT , a leading cell and gene therapy contract manufacturing organisation , today announced it is to receive a £ 1.2 million investment to collaborate with REPROCELL Europe Ltd , a UK-based stem cell company , on a project which will develop a faster , more cost-effective method of producing clinical-grade induced pluripotent stem cells .

2

10/10/2018

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

1/26/2015

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

6/21/2011

Client

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

10/10/2018

10/10/2018

1/26/2015

6/21/2011

Type

Client

Partner

Partner

Client

Business Partner

ReproCELL

Country

Japan

Subscribe to see more

Subscribe to see more

Subscribe to see more

News Snippet

Press Release: ROSLINCT and REPROCELL awarded £1.2 million from Innovate UK for clinical-grade stem cell production

Edinburgh , UK and Glasgow , UK : ROSLINCT , a leading cell and gene therapy contract manufacturing organisation , today announced it is to receive a £ 1.2 million investment to collaborate with REPROCELL Europe Ltd , a UK-based stem cell company , on a project which will develop a faster , more cost-effective method of producing clinical-grade induced pluripotent stem cells .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.